openPR Logo
Press release

Mycotoxin Testing Market is Projected to Reach $2.3 billion by 2029, at a CAGR of 6.7%

05-27-2024 08:57 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: Markets and Markets

Mycotoxin Testing Market is Projected to Reach $2.3 billion

The global mycotoxin testing market is witnessing significant growth, driven by factors such as the expansion of the agricultural sector, increasing international trade in food and agricultural products, and rising awareness of food safety among consumers and regulatory bodies. This comprehensive report delves into the intricacies of the market, examining its key drivers, challenges, and opportunities.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=229073477

Market Overview:

The market for mycotoxin testing is estimated to be USD 1.6 billion in 2024, with a projected growth to USD 2.3 billion by 2029, indicating a robust CAGR of 6.7% during the forecast period. The increasing need for mycotoxin testing arises from the necessity to comply with export regulations and maintain market access, particularly in the context of stringent regulations governing mycotoxin levels in food and feed products globally.

Technological Advancements Driving Growth:

Chromatography- and spectroscopy-based technologies are poised to experience the highest growth rate in the mycotoxin testing market. These advanced techniques offer unparalleled sensitivity and selectivity, enabling precise detection of mycotoxins even at minute concentrations within complex food and feed matrices. Moreover, their ability to simultaneously analyze multiple mycotoxins in a single sample ensures comprehensive risk assessment and regulatory compliance.

Read more: https://www.prnewswire.com/news-releases/mycotoxin-testing-market-worth-2-3-billion-by-2029--exclusive-report-by-marketsandmarkets-302155011.html

Key Type Segment: Ochratoxin Testing

Ochratoxin constitutes a significant share in the mycotoxin testing market, primarily due to its substantial health risks to humans and animals. Identified as a potent nephrotoxin and carcinogen, ochratoxin contamination poses considerable threats, necessitating thorough testing protocols to ensure its absence or minimal presence in food and feed products. Moreover, ochratoxin contamination is prevalent across a wide array of agricultural commodities, further underscoring the importance of regular testing to mitigate risks and ensure compliance with regulatory standards.

Regional Insights:

Europe emerges as the largest market for mycotoxin testing in terms of value. The region's stringent regulatory standards regarding food safety compel rigorous testing for mycotoxin contamination to ensure compliance. The European Union, in particular, has established maximum limits for various mycotoxins in food and feed products, driving the demand for comprehensive testing protocols. Additionally, Europe's robust food and agriculture industry, coupled with its emphasis on quality and safety standards, further reinforces its leadership in mycotoxin testing.

Make an Inquiry: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=229073477

Key Players Driving Innovation:

The mycotoxin testing market is characterized by the presence of key players such as SGS Société Générale de Surveillance SA, Bureau Veritas, Intertek Group plc, Eurofins Scientific, and others. These companies are at the forefront of innovation, continuously striving to enhance testing methodologies and develop advanced solutions to meet the evolving needs of the market. From technological advancements to regulatory compliance, these players play a pivotal role in shaping the landscape of the global mycotoxin testing market.

Conclusion:

As the global food industry continues to evolve, ensuring the safety and quality of food and feed products remains paramount. The mycotoxin testing market, driven by technological advancements, regulatory mandates, and increasing consumer awareness, is poised for substantial growth in the coming years. By embracing innovation and collaboration, stakeholders can navigate the complexities of this dynamic market landscape and contribute to safeguarding public health and enhancing food safety standards worldwide.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Mycotoxin Testing Market is Projected to Reach $2.3 billion by 2029, at a CAGR of 6.7% here

News-ID: 3513002 • Views:

More Releases from Markets and Markets

Controlled-release Fertilizers Market Latest Trends, Demands, Overview and Analysis by 2028
Controlled-release Fertilizers Market Latest Trends, Demands, Overview and Analy …
The controlled-release fertilizers market is experiencing notable growth, estimated at USD 2.2 billion in 2023 and projected to reach USD 2.9 billion by 2028. This reflects a compound annual growth rate (CAGR) of 5.9% during the forecast period. The demand for controlled-release fertilizers is increasing due to their benefits in enhancing nutrient efficiency, reducing environmental impact, and supporting sustainable agricultural practices. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=136099624 These fertilizers are prized for their ability
Gelatin Market is Projected to Reach $5.6 billion by 2029, at a CAGR of 6.9% from 2024 to 2029
Gelatin Market is Projected to Reach $5.6 billion by 2029, at a CAGR of 6.9% fro …
According to a research report titled "Gelatin Market by Source (Animal, Plants), By Applications (Food & Beverages, Pharmaceuticals, Health & Nutrition, Cosmetics, Personal Care, Animal Feed), Type (Type A, Type B), Function (Thickener, Stabilizer, Gelling Agent) - Global Forecast to 2029," published by MarketsandMarkets, the gelatin market is poised for significant growth. The market, valued at USD 4.0 billion in 2024, is projected to reach USD 5.6 billion by 2029,
Facility Management Market Status, Revenue, Growth Rate, Services and Solutions
Facility Management Market Status, Revenue, Growth Rate, Services and Solutions
According to a research report "Facility Management Market by Offering (Solutions (IWMS, BIM, Facility Operations & Security Management) and Services), Vertical (BFSI, Retail, Construction & Real Estate, Healthcare & Life sciences) and Region - Global Forecast to 2028" published by MarketsandMarkets, the facility management market is estimated at USD 49.6 billion in 2023 to USD 94.8 billion by 2028, at a Compound Annual Growth Rate (CAGR) of 13.8%. Download PDF Brochure:
Endpoint Security Market Size, Revenue, Growth Rate Analysis and Forecast 2024
Endpoint Security Market Size, Revenue, Growth Rate Analysis and Forecast 2024
According to a research report "Endpoint Security Market by Solution (Endpoint Protection Platform and Endpoint Detection and Response), Service, Deployment Mode, Organization Size, Vertical (Healthcare, Retail and eCommerce, and Government), and Region - Global Forecast to 2024", published by MarketsandMarkets, the global endpoint security market size is expected to grow from USD 12.8 billion in 2019 to USD 18.4 billion by 2024, at a Compound Annual Growth Rate (CAGR) of

All 5 Releases


More Releases for MarketsandMarkets™

Biomaterials Market Worth $64.2 billion | MarketsandMarkets™
Biomaterials Market in terms of revenue was estimated to be worth $45.2 billion in 2024 and is poised to reach $64.2 billion by 2029, growing at a CAGR of 7.3% from 2024 to 2029 according to a new report by MarketsandMarkets™. The biomaterials market is estimated to grow at a CAGR of 7.3% during the forecast period of 2024 to 2029. The important factors impacting market growth are the growing
Cell Expansion Market Worth $26.7 billion | MarketsandMarkets™
Cell Expansion Market in terms of revenue was estimated to be worth $14.3 billion in 2024 and is poised to reach $26.7 billion by 2029, growing at a CAGR of 13.3% from 2024 to 2029 according to a new report by MarketsandMarkets™. Some factors contributing to the growth of the global market includes increasing R&D investments in cell based research, growing focus on personalized medicine, and increasing number of strategic
Apheresis Market Worth $3.9 billion | MarketsandMarkets™
Apheresis Market in terms of revenue was estimated to be worth $2.6 billion in 2024 and is poised to reach $3.9 billion by 2029, growing at a CAGR of 8.8% from 2024 to 2029 according to a new report by MarketsandMarkets™. The growth in the apheresis market is driven by rise in demand for source plasma from biopharmaceutical companies, upsurging demand for blood components and favourable reimbursement for apheresis. The increasing
Medical Robots Market Worth $33.8 billion | MarketsandMarkets™
Medical Robots Market in terms of revenue was estimated to be worth $16.0 billion in 2024 and is poised to reach $33.8 billion by 2029, growing at a CAGR of 16.1% from 2024 to 2029 according to a new report by MarketsandMarkets™. The growth in the medical robots market is driven by the aging population and rising chronic diseases, improving reimbursement scenario, and subsequent advancements in healthcare funding & infrastructure.
Pipette Calibrators Market Worth $391 million | MarketsandMarkets™
Pipette Calibrators Market in terms of revenue was estimated to be worth $286 million in 2024 and is poised to reach $391 million by 2029, growing at a CAGR of 6.5% from 2024 to 2029 according to a new report by MarketsandMarkets™. The growth of this market is majorly driven by rise in genomics and proteomics research, growth in portable and handheld devices, and establishment of new research facilities by pharmaceutical
Mice Model Market Worth $2.2 billion | MarketsandMarkets™
Mice Model Market in terms of revenue was estimated to be worth $1.5 billion in 2024 and is poised to reach $2.2 billion by 2029, growing at a CAGR of 8.1% from 2024 to 2029 according to a new report by MarketsandMarkets™. The rise in chronic diseases, such as cancer, diabetes, and cardiovascular disorders, and growing need for reliable and predictive animal models to facilitate drug discovery and development are